 SEATTLE--BUSINESS WIRE--Alpine Immune Sciences, Inc. Nasdaq: ALPN, a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer and autoimmune and inflammatory diseases, today announced that members of its management team will participate at the following investor conferences in May 2022: LifeSci Partners Immunology Inflammation Symposium Date: Tuesday, May 10, 2022 Time: 3:00 p.m. ET12:00 p.m. PT Event: Fireside Chat BofA Securities Healthcar 